TOP TEN perturbations for 38585_at (Homo sapiens)
Organism: Homo sapiens
Gene: 38585_at
Selected probe(set): 205919_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38585_at (205919_at) across 6674 perturbations tested by GENEVESTIGATOR:
stem cell differentiation study 41 (T3pi) / stem cell differentiation study 41 (hES-T3 EB)
Relative Expression (log2-ratio):-5.366337Number of Samples:2 / 2
| Experimental | stem cell differentiation study 41 (T3pi) |
| Sample of pancreatic islet-like cell clusters differentiated from human embryonic stem cells T3 with female karyotype. | |
| Control | stem cell differentiation study 41 (hES-T3 EB) |
| Sample of embryonic bodies (EB) differentiated from human embryonic stem cells T3 with female karyotype. |
lung cancer study 1 (PDX; non-small cell carcinoma; primary) / lung cancer study 1 (PDX; adenocarcinoma, NOS; primary)
Relative Expression (log2-ratio):5.305649Number of Samples:2 / 22
| Experimental | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; adenocarcinoma, NOS; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary adenocarcinoma, NOS of the lung (subcutaneously implanted). |
lung cancer study 1 (PDX; squamous cell carcinoma, NOS; primary) / lung cancer study 1 (PDX; non-small cell carcinoma; primary)
Relative Expression (log2-ratio):-5.298707Number of Samples:43 / 2
| Experimental | lung cancer study 1 (PDX; squamous cell carcinoma, NOS; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary squamous cell carcinoma, NOS of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). |
lung cancer study 1 (PDX; non-small cell carcinoma; primary) / lung cancer study 1 (PDX; basaloid carcinoma; primary)
Relative Expression (log2-ratio):5.1670284Number of Samples:2 / 3
| Experimental | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; basaloid carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary basaloid carcinoma of the lung (subcutaneously implanted). |
lung cancer study 1 (PDX; pseudosarcomatous carcinoma; primary) / lung cancer study 1 (PDX; non-small cell carcinoma; primary)
Relative Expression (log2-ratio):-5.092147Number of Samples:4 / 2
| Experimental | lung cancer study 1 (PDX; pseudosarcomatous carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary pseudosarcomatous carcinoma of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). |
lung cancer study 1 (PDX; non-small cell carcinoma; primary) / lung cancer study 1 (PDX; adenosquamous carcinoma; primary)
Relative Expression (log2-ratio):5.0825396Number of Samples:2 / 4
| Experimental | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; adenosquamous carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary adenosquamous carcinoma of the lung (subcutaneously implanted). |
gestational age study 1 (term) / elective termination placenta (1st trim.) tissue
Relative Expression (log2-ratio):-4.9908953Number of Samples:4 / 4
| Experimental | gestational age study 1 (term) |
| Term human placenta samples obtained from scheduled uncomplicated C-sections. | |
| Control | elective termination placenta (1st trim.) tissue |
| First trimester placenta samples (45-59 days) obtained from uncomplicated elective termination. |
lung cancer study 1 (PDX; non-small cell carcinoma; primary) / lung cancer study 1 (PDX; large cell carcinoma, NOS; primary)
Relative Expression (log2-ratio):4.783478Number of Samples:2 / 4
| Experimental | lung cancer study 1 (PDX; non-small cell carcinoma; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary non-small cell carcinoma of the lung (subcutaneously implanted). | |
| Control | lung cancer study 1 (PDX; large cell carcinoma, NOS; primary) |
| Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary large cell carcinoma, NOS of the lung (subcutaneously implanted). |
myotonic dystrophy study 4 (biceps brachii; DM2) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-4.692192Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (biceps brachii; DM2) |
| Biceps brachii biopsies obtained from patients with myotonic dystrophy type 2 (DM2). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Duchenne muscular dystrophy study 9 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-4.601653Number of Samples:2 / 3
| Experimental | Duchenne muscular dystrophy study 9 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Duchenne muscular dystrophy DMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Organism: Homo sapiens
Gene: 38585_at
Selected probe(set): 204419_x_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38585_at (204419_x_at) across 6674 perturbations tested by GENEVESTIGATOR:
collecting duct carcinoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-8.113667Number of Samples:2 / 2
| Experimental | collecting duct carcinoma study 1 |
| Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
Duchenne muscular dystrophy study 9 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-8.09399Number of Samples:2 / 3
| Experimental | Duchenne muscular dystrophy study 9 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Duchenne muscular dystrophy DMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Becker muscular dystrophy study 3 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.978812Number of Samples:3 / 3
| Experimental | Becker muscular dystrophy study 3 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Becker muscular dystrophy (BMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 5 (papillary type) / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.9554625Number of Samples:19 / 2
| Experimental | renal cell carcinoma study 5 (papillary type) |
| Tumor tissue samples from the kidney of patients with papillary renal cell carcinoma (pRCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
oxyphilic adenoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.8476534Number of Samples:4 / 2
| Experimental | oxyphilic adenoma study 1 |
| Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (skeletal muscle; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.6856956Number of Samples:5 / 3
| Experimental | myotonic dystrophy study 4 (skeletal muscle; DM1) |
| Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 4 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.6255245Number of Samples:26 / 2
| Experimental | renal cell carcinoma study 4 |
| Tumor tissue samples from the kidney of patients with renal cell carcinoma (RCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (deltoid muscle; DM-like) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.390436Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (deltoid muscle; DM-like) |
| Deltoid muscle biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
nephroblastoma study 2 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.364477Number of Samples:4 / 2
| Experimental | nephroblastoma study 2 |
| Tumor tissue samples from the kidney of patients with Wilms’ tumor. | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (biceps brachii; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.2787066Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (biceps brachii; DM1) |
| Biceps brachii biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Organism: Homo sapiens
Gene: 38585_at
Selected probe(set): 204419_x_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38585_at (204419_x_at) across 6674 perturbations tested by GENEVESTIGATOR:
collecting duct carcinoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-8.113667Number of Samples:2 / 2
| Experimental | collecting duct carcinoma study 1 |
| Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
Duchenne muscular dystrophy study 9 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-8.09399Number of Samples:2 / 3
| Experimental | Duchenne muscular dystrophy study 9 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Duchenne muscular dystrophy DMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Becker muscular dystrophy study 3 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.978812Number of Samples:3 / 3
| Experimental | Becker muscular dystrophy study 3 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Becker muscular dystrophy (BMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 5 (papillary type) / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.9554625Number of Samples:19 / 2
| Experimental | renal cell carcinoma study 5 (papillary type) |
| Tumor tissue samples from the kidney of patients with papillary renal cell carcinoma (pRCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
oxyphilic adenoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.8476534Number of Samples:4 / 2
| Experimental | oxyphilic adenoma study 1 |
| Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (skeletal muscle; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.6856956Number of Samples:5 / 3
| Experimental | myotonic dystrophy study 4 (skeletal muscle; DM1) |
| Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 4 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.6255245Number of Samples:26 / 2
| Experimental | renal cell carcinoma study 4 |
| Tumor tissue samples from the kidney of patients with renal cell carcinoma (RCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (deltoid muscle; DM-like) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.390436Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (deltoid muscle; DM-like) |
| Deltoid muscle biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
nephroblastoma study 2 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.364477Number of Samples:4 / 2
| Experimental | nephroblastoma study 2 |
| Tumor tissue samples from the kidney of patients with Wilms’ tumor. | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (biceps brachii; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.2787066Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (biceps brachii; DM1) |
| Biceps brachii biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Organism: Homo sapiens
Gene: 38585_at
Selected probe(set): 204419_x_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38585_at (204419_x_at) across 6674 perturbations tested by GENEVESTIGATOR:
collecting duct carcinoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-8.113667Number of Samples:2 / 2
| Experimental | collecting duct carcinoma study 1 |
| Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
Duchenne muscular dystrophy study 9 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-8.09399Number of Samples:2 / 3
| Experimental | Duchenne muscular dystrophy study 9 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Duchenne muscular dystrophy DMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
Becker muscular dystrophy study 3 (biceps brachii) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.978812Number of Samples:3 / 3
| Experimental | Becker muscular dystrophy study 3 (biceps brachii) |
| Biceps brachii biopsies obtained from patients with Becker muscular dystrophy (BMD). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 5 (papillary type) / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.9554625Number of Samples:19 / 2
| Experimental | renal cell carcinoma study 5 (papillary type) |
| Tumor tissue samples from the kidney of patients with papillary renal cell carcinoma (pRCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
oxyphilic adenoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.8476534Number of Samples:4 / 2
| Experimental | oxyphilic adenoma study 1 |
| Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (skeletal muscle; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.6856956Number of Samples:5 / 3
| Experimental | myotonic dystrophy study 4 (skeletal muscle; DM1) |
| Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
renal cell carcinoma study 4 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.6255245Number of Samples:26 / 2
| Experimental | renal cell carcinoma study 4 |
| Tumor tissue samples from the kidney of patients with renal cell carcinoma (RCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (deltoid muscle; DM-like) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.390436Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (deltoid muscle; DM-like) |
| Deltoid muscle biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |
nephroblastoma study 2 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):-7.364477Number of Samples:4 / 2
| Experimental | nephroblastoma study 2 |
| Tumor tissue samples from the kidney of patients with Wilms’ tumor. | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
myotonic dystrophy study 4 (biceps brachii; DM1) / normal skeletal muscle tisuue (fetal)
Relative Expression (log2-ratio):-7.2787066Number of Samples:3 / 3
| Experimental | myotonic dystrophy study 4 (biceps brachii; DM1) |
| Biceps brachii biopsies obtained from patients with myotonic dystrophy type 1 (DM1). | |
| Control | normal skeletal muscle tisuue (fetal) |
| Commercially purchased normal fetal skeletal muscle tissue samples. |